Skip to content

Acute Effects of Wine Consumption on Healthy Volunteers

Acute Effects of Wine Consumption on Platelet Aggregation, and on Inflammatory / Oxidative Stress Markers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01627912
Acronym
winepost
Enrollment
10
Registered
2012-06-26
Start date
2011-04-30
Completion date
2012-10-31
Last updated
2012-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Postprandial

Keywords

wine, inflammation, oxidative stress, randomized control trial, postprandial intervention, platelet aggregation, haemostasis, robola, cabernet sauvignon, alcohol, PAF metabolism

Brief summary

The purpose of this study is to investigate whether red and white wine consumption has acute effects on postprandial biochemical markers related to platelet aggregation, inflammation and oxidative stress compared to water or 12.5% ethanol aqueous solution consumption.

Detailed description

The last few years, epidemiologic studies indicate that regular moderate consumption of alcohol is associated with lower risk of coronary heart disease and heart attack, as well as with lower mortality. More specific, a J or U-shaped association between alcohol consumption and the incidence of coronary heart disease have been suggested, which means that there was lower disease risk in moderate alcohol consumers than in abstainers or heavy drinkers. The scientific interest was focused on wine after the term French paradox was introduced, in order to describe the epidemiological observation that the French suffer a relatively low incidence of coronary heart disease, despite having a diet relatively rich in saturated fats. The paradox was attributed to the moderate consumption of red wine by French. Even though many clinical studies have occurred since then, only few of them report the postprandial effect of wine, mainly focusing on the study of oxidative stress markers and endothelium dysfunction. Also, a limited number of publications refer to the postprandial wine effect upon platelet aggregation, which is an indicative marker for inflammation / thrombosis and atherosclerosis. The limited clinical evidence prompted us to investigate the postprandial effect of wine consumption upon platelet aggregation, inflammation and oxidation markers, by undertaking a clinical study of crossover design. The subjects randomly consumed 4ml of drink \[Robola or Cabernet Sauvignon or 12.5% ethanol or water\]/kg of individual, parallel with a standardized meal, which consisted of 30.8% carbohydrates, 12.0% proteins and 53.1% fat. The meal total energy was 787.2 kcal.

Interventions

OTHERRobola, Cabernet Sauvignon wines

4 treatments on separate days: the subjects randomly consumed 4ml of drink \[white wine or red wine or 12.5% ethanol or water\]/kg of individual, parallel with a standardized meal.

Sponsors

Graduate Program of the Department of Nutrition and Dietetics
CollaboratorUNKNOWN
Harokopio University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
26 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy * non-obese

Exclusion criteria

* smokers * those who reported slimming or any other dietary regime * abstainers from alcohol consumption * heavy drinkers * athletes * subjects who were on medication, such as aspirin, that may have an impact on platelet aggregation or surgical events that may have affected the study outcomes * participants with a known diagnosis of either hypertension or diabetes * subjects on medication

Design outcomes

Primary

MeasureTime frameDescription
platelet aggregationbaselineIn each time point platelet rich plasma (PRP) was isolated from the blood of volunteers and platelet aggregation upon Platelet activating factor (PAF) was measured in CHRONO-LOG aggregometer.
markers of inflammationbaseline
markers of oxidative stressbaselineTBARS, ex vivo serum oxidation etc
PAF metabolism0 min after standardized meal plus tested drink consumptionMeasurement of PAF biosynthetic / catabolic enzymes in leucocytes and LpPLA2 in serum

Secondary

MeasureTime frameDescription
Insulin levels0 min after standardized meal plus tested drink consumption
lipidsbaselineHDL-cholesterol, LDL-cholesterol, total chlesterol, triglycerides
Glucose levelsbaseline

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026